- Home
- KROS vs MLAB Comparison
KROS vs MLAB Comparison
Compare KROS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | MLAB |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 489.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | MLAB |
|---|---|---|
| Price | $16.57 | $91.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $23.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 266.1K | 82.7K |
| Earning Date | 03-03-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | 0.68 |
| Revenue | $246,718,000.00 | ★ $247,541,000.00 |
| Revenue This Year | $6,924.79 | $4.96 |
| Revenue Next Year | N/A | $4.85 |
| P/E Ratio | ★ $10.53 | $133.17 |
| Revenue Growth | ★ 37798.31 | 4.12 |
| 52 Week Low | $9.12 | $55.45 |
| 52 Week High | $22.55 | $152.03 |
Technical Indicators
Market Signals| Indicator | KROS | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 57.64 |
| Support Level | $16.31 | $85.91 |
| Resistance Level | $17.17 | $94.38 |
| Average True Range (ATR) | 0.63 | 4.14 |
| MACD | -0.13 | 0.39 |
| Stochastic Oscillator | 18.26 | 60.61 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.